LAG3 and neoplasm: HLA-II over-expression by tumor cells (92) and fibrinogen-like 1 (FGL1), a protein secreted by liver cells and tumor cells (46), are ligands of LAG-3, and their secretion impact the expression of LAG-3 in T cells, promoting an immunosuppressive function.